Whalesbook
Resonance Specialties Ltd has reported robust financial results for the fiscal year ending March 31, 2026. The company's revenue from operations grew by 16% year-on-year, reaching ₹90.25 crore compared to ₹77.81 crore in FY25.
This increased revenue fueled a significant jump in profitability. Profit after tax surged by 58%, climbing to ₹10.40 crore from ₹6.57 crore in the previous fiscal year. This substantial growth suggests improved operational efficiency or increased market demand for its specialty chemical products.
In recognition of its performance and commitment to shareholders, the Board of Directors has recommended a dividend of ₹1 per share for FY26, subject to approval at the Annual General Meeting.
Ensuring financial transparency and compliance, the company's statutory auditors, Kailash Chand Jain & Co., have been re-appointed for a five-year term. Additionally, the company will account for a ₹10.40 lakh charge in its profit and loss statement due to the implications of new labor codes.
Investors should note that the figures for the last quarter of FY26 and the corresponding period in the prior year were balancing figures derived from a limited review of full-year and unaudited year-to-date data.
The company operates in the specialty chemicals and pharmaceutical intermediates sector, producing key products such as Phthalic Anhydride and resins. Its performance is influenced by broader market dynamics common to this industry, including raw material price volatility, demand cycles, and regulatory changes, factors also impacting peers like Krishna Antioxidants Ltd and Thirumalai Chemicals Ltd.
Shareholders will be tracking the upcoming Annual General Meeting for dividend approval, the official start of the auditors' new five-year tenure, and management's commentary on future sales drivers and margin sustainability during upcoming earnings calls.